TME Pharma receives US FDA Fast Track designation for lead asset NOX-A12 in brain cancer
Fast Track designation awarded by the FDA serves as an external validation of the potential of NOX-A12 for unmet need in…
Fast Track designation awarded by the FDA serves as an external validation of the potential of NOX-A12 for unmet need in…
This protective measure underscores the significance and value of our brand in the field of spine surgery, demonstrating…
Entdecken Sie die brandaktuellen Nachrichten aus der Welt der Apotheken! In dieser Ausgabe erfahren Sie alles über die j…
Clinical trial protocol approved in the US to initiate Phase 2 study with NOX-A12 in glioblastoma providing a clear road…
At ECR 2024, Ziehm Imaging, the innovation leader for mobile C-arms, will present its extended product line for the comp…
Eight pre-selected start-ups from medicine and life sciences pitched their business ideas at the 13th BioAngels Pitch Da…
Anlässlich der Reform des Rettungsdienstes durch die Bundesregierung hat die Medizintechnik im Deutschen Industrieverban…
“Those who have worn the HoloLens 2 in the operating room see it as a true game-changer. They have the planning images i…
Kuros Biosciences (“Kuros” or “the Company”), a leader in next generation bone graft technologies, today announced it wi…
Increasing geriatric population, growing preference for minimally invasive procedures like annuloplasty and transcathete…